DRMT - Dermavant Sciences Ltd.

YHD - YHD Delayed Price. Currency in USD
At close: 6:07PM EDT
Stock chart is not supported by your current browser
Previous Close N/A
YTD Return N/A
Expense Ratio (net) N/A
Category N/A
Last Cap Gain N/A
Morningstar Rating N/A
Morningstar Risk Rating N/A
Sustainability Rating N/A
Net Assets N/A
Beta (3Y Monthly) N/A
Yield N/A
5y Average Return N/A
Holdings Turnover N/A
Last Dividend N/A
Average for Category N/A
Inception Date N/A
  • Benzinga

    Dermavant IPO: What You Need To Know

    A dermatology-focused biotech with a lucrative Phase 3 asset is set to price its IPO this week. The IPO Terms Dermavant Sciences is planning to offer 7.7 million shares in an IPO and has indicated a price ...

  • Benzinga

    IPO Outlook For The Week: Biotechs And A Grocery Outlet

    For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud . The IPO dates below are expected but not confirmed. Stoke Therapeutics, Inc. (STOK) will issue 6.7 million shares between ...

  • We're sorry this is all we were able to find about this topic.